{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:28:29Z","timestamp":1791487709618,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.humimm.2015.09.028","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T05:09:40Z","timestamp":1443848980000},"page":"729-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome"],"prefix":"10.1016","volume":"76","author":[{"given":"Sabrina","family":"Guenther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Loebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes A.","family":"Mooslechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Knops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif G.","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Wittke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Unterwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.humimm.2015.09.028_b0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: International Consensus Criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.humimm.2015.09.028_b0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.humimm.2015.09.028_b0015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1749-6632.2009.04799.x","article-title":"Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?","volume":"1173","author":"Ortega-Hernandez","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.humimm.2015.09.028_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-6-15","article-title":"Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus","volume":"6","author":"Vernon","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.humimm.2015.09.028_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1479-5876-9-81","article-title":"Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis","volume":"9","author":"Brenu","year":"2011","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2004.02354.x","article-title":"High levels of type 2 cytokine-producing cells in chronic fatigue syndrome","volume":"135","author":"Skowera","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0035","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JCM.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"10.1016\/j.humimm.2015.09.028_b0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1365-2362.1998.00373.x","article-title":"Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome","volume":"28","author":"Ogawa","year":"1998","journal-title":"Eur. J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.humimm.2015.09.028_b0045","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.139.10.3306","article-title":"Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome","volume":"139","author":"Caligiuri","year":"1987","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/mai.2003.1615","article-title":"Complement activation in a model of chronic fatigue syndrome","volume":"112","author":"Sorensen","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.028_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1995.00430010105014","article-title":"Clinical laboratory test findings in patients with chronic fatigue syndrome","volume":"155","author":"Bates","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"8","key":"10.1016\/j.humimm.2015.09.028_b0060","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"8769","key":"10.1016\/j.humimm.2015.09.028_b0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","article-title":"Chronic fatigue syndrome: clinical condition associated with immune activation","volume":"338","author":"Landay","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.humimm.2015.09.028_b0070","first-page":"477","article-title":"Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells","volume":"28","author":"Mihaylova","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"issue":"10","key":"10.1016\/j.humimm.2015.09.028_b0075","doi-asserted-by":"crossref","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0080","first-page":"399","article-title":"Clinical activity of folinic acid in patients with chronic fatigue syndrome","volume":"56","author":"Lundell","year":"2006","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","article-title":"Immunological abnormalities in patients with chronic fatigue syndrome","volume":"40","author":"Tirelli","year":"1994","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.028_b0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"Bradley","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2015.09.028_b0095","first-page":"1527","article-title":"Chronic fatigue syndrome\u2013a controlled cross sectional study","volume":"21","author":"Rasmussen","year":"1994","journal-title":"J. Rheumatol."},{"issue":"8 Suppl.","key":"10.1016\/j.humimm.2015.09.028_b0100","first-page":"S50","article-title":"Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome","volume":"9","author":"Wakefield","year":"1990","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01541666","article-title":"Immunoglobulin subclass levels in chronic fatigue syndrome","volume":"16","author":"Bennett","year":"1996","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.028_b0110","doi-asserted-by":"crossref","first-page":"e85387","DOI":"10.1371\/journal.pone.0085387","article-title":"Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome","volume":"9","author":"Loebel","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.humimm.2015.09.028_b0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(90)90173-B","article-title":"A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome","volume":"89","author":"Lloyd","year":"1990","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.humimm.2015.09.028_b0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0002-9343(90)90172-A","article-title":"A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome","volume":"89","author":"Peterson","year":"1990","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2249.2004.02616.x","article-title":"Mannan-binding lectin modulates the response to HSV-2 infection","volume":"138","author":"Gadjeva","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-3148.2002.00408.x","article-title":"Mannan-binding lectin and its role in innate immunity","volume":"12","author":"Kilpatrick","year":"2002","journal-title":"Transfus. Med. (Oxford, England)"},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.gene.6364283","article-title":"Mannose-binding lectin and its genetic variants","volume":"7","author":"Garred","year":"2006","journal-title":"Genes Immun."},{"issue":"10","key":"10.1016\/j.humimm.2015.09.028_b0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.humimm.2009.07.003","article-title":"Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency","volume":"70","author":"Hoeflich","year":"2009","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2015.09.028_b0145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/590006","article-title":"Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection","volume":"47","author":"Eisen","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2008.05.037","article-title":"Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults","volume":"122","author":"Garcia-Laorden","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2015.09.028_b0155","first-page":"688","article-title":"Mannose binding lectin (MBL) in autoimmunity and its role in systemic lupus erythematosus (SLE)","volume":"58","author":"Pradhan","year":"2010","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.humimm.2015.09.028_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"J. Chronic. Fatigue Syndr."},{"issue":"11","key":"10.1016\/j.humimm.2015.09.028_b0165","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1373\/clinchem.2003.022350","article-title":"IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents","volume":"49","author":"Schauer","year":"2003","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.humimm.2015.09.028_b0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cyto.b.20432","article-title":"Flowcytometric phenotyping of common variable immunodeficiency","volume":"74","author":"Warnatz","year":"2008","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.humimm.2015.09.028_b0175","series-title":"The Doctor\u2019s Guide to Chronic Fatigue Syndrome","author":"Bell","year":"1994"},{"issue":"6","key":"10.1016\/j.humimm.2015.09.028_b0180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3346\/jkms.2010.25.6.824","article-title":"Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.humimm.2015.09.028_b0185","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1034\/j.1600-065X.2000.17815.x","article-title":"Molecular basis of IgG subclass deficiency","volume":"178","author":"Pan","year":"2000","journal-title":"Immunol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.humimm.2015.09.028_b0190","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000234258","article-title":"Immunoglobulin G subclass deficiencies","volume":"82","author":"Soderstrom","year":"1987","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.028_b0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2249.2009.04062.x","article-title":"Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy","volume":"159","author":"Abrahamian","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2015.09.028_b0200","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1097\/MD.0000000000000387","article-title":"Serum IgG subclasses in autoimmune diseases","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.humimm.2015.09.028_b0205","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10067-009-1224-x","article-title":"IgG subclass serum levels in systemic lupus erythematosus patients","volume":"28","author":"Lin","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.humimm.2015.09.028_b0210","article-title":"Preferentially immunoglobulin (IgG) subclasses production in primary Sjogren\u2019s syndrome patients","author":"Liu","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.humimm.2015.09.028_b0215","first-page":"19","article-title":"Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS)","volume":"16","author":"Torres-Harding","year":"2008","journal-title":"Bull. IACFS\/ME"},{"issue":"5","key":"10.1016\/j.humimm.2015.09.028_b0220","first-page":"340","article-title":"Mono- and oligoclonal immunoglobulin anomalies in kidney transplant patients","volume":"34","author":"Cakalaroski","year":"2000","journal-title":"Ann. Urol."},{"issue":"1","key":"10.1016\/j.humimm.2015.09.028_b0225","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-12-1","article-title":"Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study","volume":"12","author":"Zhao","year":"2012","journal-title":"BMC Gastroenterol."},{"issue":"8","key":"10.1016\/j.humimm.2015.09.028_b0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/qjmed\/hcm057","article-title":"Symptoms of autonomic dysfunction in chronic fatigue syndrome","volume":"100","author":"Newton","year":"2007","journal-title":"QJM"},{"issue":"23","key":"10.1016\/j.humimm.2015.09.028_b0235","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1002\/cncr.27612","article-title":"Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults","volume":"118","author":"Chang","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.humimm.2015.09.028_b0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.humimm.2009.01.022","article-title":"Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection","volume":"70","author":"Seppanen","year":"2009","journal-title":"Hum. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915004656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:24:42Z","timestamp":1692051882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0198885915004656"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.028","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}